Abstract
Hypophosphatemia associated with bone marrow transplantation has been infrequently reported. The suggested mechanism is phosphate uptake by the replicating cells. Various cytokines are associated with the development of hypophosphatemia. The present study evaluated the interrelationship between cytokine release, the rise in WBC and the development of hypophosphatemia during the engraftment period. Blood samples were obtained from 60 patients undergoing peripheral blood stem cell transplant, on the day of admission and then daily from the day of transplant until discharge. Hypophosphatemia developed in 62% of the patients. The median day of minimal phosphorus level was +8 and it antedated engraftment by 2 days. There was a significant correlation between the day of minimal phosphorus level and the day of maximal WBC and a significant correlation between the fall in phosphorus level and WBC rise. IL-6 and IL-8 showed similar kinetics. Higher IL-6 and IL-8 levels were directly associated with lower phosphorus levels. In conclusion, hypophosphatemia commonly occurs in the post-transplant period. We assume that both a direct effect of cytokine release and an increased consumption by the dividing WBCs contribute to its appearance. As its occurrence usually antedates engraftment it can be used as a forerunner for WBC recovery. Bone Marrow Transplantation (2001) 27, 311–317.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Betro MG, Pain RW . Hypophosphataemia and hyperphosphataemia in a hospital population Br Med J 1972 1: 273–276
Ra'anani P, Lahav M, Prokocimer M et al. Life threatening hypophosphataemia in a patient with Philadelphia chromosome-positive chronic myelogenous leukaemia in acute blastic crisis Postgrad Med J 1992 68: 283–286
Clark RE, Lee ES . Severe hypophosphataemia during stem cell harvesting in chronic myeloid leukaemia Br J Haematol 1995 90: 450–452
Raanani P, Berkowicz M, Harden I, Ben-Bassat I . Severe hypophosphataemia in autograft recipients during accelerated leucocyte recovery Br J Haematol 1995 91: 1031–1032
Crook MA, Schey S . Bone marrow transplantation and severe hypophosphataemia Br J Haematol 1996 93: 250
Crook M, Swaminathan R, Schey S . Hypophosphataemia in patients undergoing bone marrow transplantation Leuk Lymphoma 1996 22: 335–337
Schwaighofer H, Herold M, Schwarz T et al. Serum levels of interleukin 6, interleukin 8, and C-reactive protein after human allogeneic bone marrow transplantation Transplantation 1994 58: 430–436
Rabinowitz J, Petros WP, Stuart AR, Peters WP . Characterization of endogenous cytokine concentrations after high-dose chemotherapy with autologous bone marrow support Blood 1993 81: 2452–2459
Ferra C, de Sanjose S, Gallardo D et al. IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation Haematologica 1998 83: 1082–1087
Baiocchi G, Scambia G, Benedetti P et al. Autologous stem cell transplantation: sequential production of hematopoietic cytokines underlying granulocyte recovery Cancer Res 1993 53: 1297–1303
Chasty RC, Lamb WR, Gallati H et al. Serum cytokine levels in patients undergoing bone marrow transplantation Bone Marrow Transplant 1993 12: 331–336
Rowbottom AW, Riches PG, Downie C, Hobbs JR . Monitoring cytokine production in peripheral blood during acute graft-versus-host disease following allogeneic bone marrow transplantation Bone Marrow Transplant 1993 12: 635–641
Testa U, Martucci R, Rutella S et al. Autologous stem cell transplantation: release of early and late acting growth factors relates with hematopoietic ablation and recovery Blood 1994 84: 3532–3539
Uchiyama H, Shimazaki C, Fujita N et al. Kinetics of serum cytokines in adults undergoing peripheral blood progenitor cell transplantation Br J Haematol 1994 88: 639–642
Steffen M, Durken M, Pichlmeier U et al. Serum interleukin-6 levels during bone marrow transplantation: impact on transplant-related toxicity and engraftment Bone Marrow Transplant 1996 18: 301–307
Remberger M, Ringden O, Markling L . TNF alpha levels are increased during bone marrow transplantation conditioning in patients who develop acute GVHD Bone Marrow Transplant 1995 15: 99–104
Lee CK, Gingrich RD, Hohl RJ, Ajram KA . Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation Bone Marrow Transplant 1995 16: 175–182
Ravoet C, Feremans W, Husson B et al. Clinical evidence for an engraftment syndrome associated with early and steep neutrophil recovery after autologous blood stem cell transplantation Bone Marrow Transplant 1996 18: 943–947
Cahill RA, Spitzer TR, Mazumder A . Marrow engraftment and clinical manifestations of capillary leak syndrome Bone Marrow Transplant 1996 18: 177–184
Nagler A, Bishara A, Brautbar C, Barak V . Dysregulation of inflammatory cytokines in unrelated bone marrow transplantation Cytokines Cell Mol Ther 1998 4: 161–167
Caracciolo D, Clark SC, Rovera G . Human interleukin-6 supports granulocytic differentiation of hematopoietic progenitor cells and acts synergistically with GM-CSF Blood 1989 73: 666–670
Terashima T, English D, Hogg JC, van Eeden SF . Release of polymorphonuclear WBCs from the bone marrow by interleukin-8 Blood 1998 92: 1062–1069
Ericson SG, Zhao Y, Gao H . Interleukin-6 production by human neutrophils after Fc-receptor cross-linking or exposure to granulocyte colony-stimulating factor Blood 1998 91: 2099–2107
Barak V, Schwartz A, Kalickman I et al. Prevalence of HP in sepsis and infection: the role of cytokines Am J Med 1998 104: 40–47
Sarmiento UM, Riley JH, Knaack PA et al. Biologic effects of recombinant human interleukin-12 in squirrel monkeys (Sciureus saimiri) Lab Invest 1994 71: 862–873
Mavligit GM, Zukiwski AA, Charnsangavej C et al. Regional biologic therapy. Hepatic arterial infusion of recombinant human tumor necrosis factor in patients with liver metastases Cancer 1992 69: 557–561
del Giglio A, Zukiwski AA, Ali MK, Mavligit GM . Severe, symptomatic, dose-limiting HP induced by hepatic arterial infusion of recombinant tumor necrosis factor in patients with liver metastases Cancer 1991 67: 2459–2461
Webb DE, Austin HA III, Belldegrun A et al. Metabolic and renal effects of interleukin-2 immunotherapy for metastatic cancer Clin Nephrol 1988 30: 141–145
Kozeny GA, Nicolas JD, Creekmore S et al. Effects of interleukin-2 immunotherapy on renal function J Clin Oncol 1988 6: 1170–1176
Belldegrun A, Webb DE, Austin HA III et al. Renal toxicity of interleukin-2 administration in patients with metastatic renal cell cancer: effect of pre-therapy nephrectomy J Urol 1989 141: 499–503
Chopra R, McMillan AK, Linch DC et al. The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients Blood 1993 81: 1137–1145
Tutschka PJ, Copelan EA, Klein JP . Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen Blood 1987 70: 1382–1388
Crook M . Hypophosphataemia in a hospital population and the incidence of concomitant hypokalaemia Ann Clin Biochem 1992 29: 64–66
Vannatta JB, Whang R, Papper S . Efficacy of intravenous phosphorus therapy in the severely hypophosphatemic patient Arch Intern Med 1981 141: 885–887
Knochel JP . The pathophysiology and clinical characteristics of severe HP Arch Intern Med 1977 137: 203–220
de Bont ES, Vellenga E, Swaanenburg JC et al. Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia Br J Haematol 1999 107: 375–380
Humar A, St Louis P, Mazzulli T et al. Elevated serum cytokines are associated with cytomegalovirus infection and disease in bone marrow transplant recipients J Infect Dis 1999 179: 484–488
Acknowledgements
This research was supported by a grant from the Israel Cancer Association through the Estate of the late Ethel Cohen. The authors thank all the nurses of the Hemato-Oncology unit at the Sheba Medical Center for their active participation in the treatment of the patients in this study and for obtaining all the blood samples.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Raanani, P., Levi, I., Holzman, F. et al. Engraftment-associated hypophosphatemia – the role of cytokine release and steep leukocyte rise post stem cell transplantation. Bone Marrow Transplant 27, 311–317 (2001). https://doi.org/10.1038/sj.bmt.1702761
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702761